The oleaginous yeast Yarrowia lipolytica is an organism of choice for the tailored production of various compounds such as biofuels or biopolymers. When properly engineered, it is capable of producing medium-chain-length polyhydroxyalkanoate (mcl-PHA), a biobased and biodegradable polymer that can be used as bioplastics or biopolymers for environmental and biomedical applications. This study describes the bioproduction and the main properties of two different mcl-PHA polymers. We generated by metabolic engineering, strains of Y. lipolytica capable of accumulating more than 25% (g/g) of mcl-PHA polymers. Depending of the strain genetic background and the culture conditions, we produced (i) a mcl-PHA homopolymer of 3-hydroxydodecanoic acids, with a mass-average molar mass (Mw) of 316,000 g/mol, showing soft thermoplastic properties with potential applications in packaging and (ii) a mcl-PHA copolymer made of 3-hydroxyoctanoic (3HO), decanoic (3HD), dodecanoic (3HDD) and tetradecanoic (3TD) acids with a Mw of 128,000 g/mol, behaving like a thermoplastic elastomer with potential applications in biomedical material. The ability to engineer Y. lipolytica to produce tailored PHAs together with the range of possible applications regarding their biophysical and mechanical properties opens new perspectives in the field of PHA bioproduction.
Siderophores are small metal chelators synthesized by numerous organisms to access iron. These secondary metabolites are ubiquitously present on Earth, and because their production represents the main strategy to assimilate iron, they play an important role in both positive and negative interactions between organisms. In addition, siderophores are used in biotechnology for diverse applications in medicine, agriculture and the environment. The generation of non-natural siderophore analogs provides a new opportunity to create new-to-nature chelating biomolecules that can offer new properties to expand applications. This review summarizes the main strategies of combinatorial biosynthesis that have been used to generate siderophore analogs. We first provide a brief overview of siderophore biosynthesis, followed by a description of the strategies, namely, precursor-directed biosynthesis, the design of synthetic or heterologous pathways and enzyme engineering, used in siderophore biosynthetic pathways to create diversity. In addition, this review highlights the engineering strategies that have been used to improve the production of siderophores by cells to facilitate their downstream utilization.
Summary: Iron plays a key role in microbial metabolism and bacteria have developed multiple siderophore‐driven mechanisms due to its poor bioavailability for organisms in the environment. Iron‐bearing minerals generally serve as a nutrient source to sustain bacterial growth after bioweathering. Siderophores are high‐affinity ferric iron chelators, of which the biosynthesis is tightly regulated by the presence of iron. Pyoverdine‐producing Pseudomonas have shown their ability to extract iron and magnesium from asbestos waste as nutrients. However, such bioweathering is rapidly limited due to repression of the pyoverdine pathway and the low bacterial requirement for iron. We developed a metabolically engineered strain of Pseudomonas aeruginosa for which pyoverdine production was no longer repressed by iron as a proof of concept. We compared siderophore‐promoted dissolution of flocking asbestos waste by this optimized strain to that by the wild‐type strain. Interestingly, pyoverdine production by the optimized strain was seven times higher in the presence of asbestos waste and the dissolution of magnesium and iron from the chrysotile fibres contained in flocking asbestos waste was significantly enhanced. This innovative mineral weathering process contributes to remove toxic iron from the asbestos fibres and may contribute to the development of an eco‐friendly method to manage asbestos waste.
The engineering of non ribosomal peptide synthetases (NRPS) for new substrate specificity is a potent strategy to incorporate non-canonical amino acids into peptide sequences, thereby creating peptide diversity and broadening applications. The non-ribosomal peptide pyoverdine is the primary siderophore produced by Pseudomonas aeruginosa and holds biomedical promise in diagnosis, bio-imaging and antibiotic vectorization. We engineered the adenylation domain of PvdD, the terminal NRPS in pyoverdine biosynthesis, to accept a functionalized amino acid. Guided by molecular modeling, we rationally designed mutants of P. aeruginosa with mutations at two positions in the active site. A single amino acid change results in the successful incorporation of an azido-l-homoalanine leading to the synthesis of a new pyoverdine analog, functionalized with an azide function. We further demonstrated that copper free click chemistry is efficient on the functionalized pyoverdine and that the conjugated siderophore retains the iron chelation properties and its capacity to be recognized and transported by P. aeruginosa. The production of clickable pyoverdine holds substantial biotechnological significance, paving the way for numerous downstream applications.
Pyoverdines (PVDs) are fluorescent siderophores produced by many Pseudomonas species. In P. aeruginosa, the TonB-dependent transporters (TBDT) FpvA and FpvB mediate PVD-dependent iron acquisition. PVDs have emerged as promising vectors for antibiotics in antibacterial Trojan horse strategies. However, the uptake of PVD-antibiotic conjugates by FpvA and FpvB remains poorly characterized. Here, we report the semisynthesis of a PVD-oxazolidine conjugate used as a molecular tool to investigate how P. aeruginosa accesses iron via these TBDTs in the presence of two native PVDs and their corresponding antibiotic conjugates. Growth assays demonstrate that P. aeruginosa can access iron chelated by PVDs through both FpvA and FpvB. In contrast, although both antibiotic conjugates provide iron to the strain via FpvA, only one does so via FpvB, indicating differential receptor recognition. Docking analyses reveal that native PVDs adopt similar binding modes within both FpvA and FpvB. However, FpvB-previously described as a broadly selective transporter-exhibits selective restriction toward PVD-antibiotic conjugates. Our results provide insights for the design of PVD-antibiotic conjugates and emphasize the critical role of the conjugation site on PVD in ensuring efficient transporter-mediated uptake.